Brief: Lisata Therapeutics Inc Reports Quarterly Loss Per Share Of $0.76
30/03/2023 21:37
March 30 (Reuters) - Lisata Therapeutics Inc LSTA.O :
* LISATA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* LISATA THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.76
Source text for Eikon: ID:nGNXbS4Q7J
Further company coverage: LSTA.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics - Amends Merger Offer Price To $4 Per Share Plus CVR
Brief: Lisata Therapeutics Enters Into Definitive Agreement To Be Acquired By Kuva Labs, Inc.
U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies
Lisata jumps as Kuva Labs strikes acquisition deal